老虎證券

美股詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務

泰和誠醫療

4.24
0.0000
成交量：723.00
成交額：3,159.96
市值：1,840.88萬
市盈率：-0.81
高：4.56
開：4.56
低：4.21
收：4.24
52周最高：10.77
52周最低：3.54
股本：434.17萬
流通股本：140.25萬
量比：0.06
換手率：0.05%
股息：- -
股息率：- -
每股收益(TTM):-5.2432
每股收益(LYR):-9.6671
淨資產收益率：-29.03%
總資產收益率：-4.48%
市淨率：-0.06
市盈率(LYR):-0.44

資料載入中...

總覽公司新聞資訊公告
2025/04/25

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/04/19

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/08/17

SEC問詢函

Form CORRESP - Correspondence
2023/07/14

SEC問詢函

Form CORRESP - Correspondence
2023/04/19

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/04/29

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/08/26

財報披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/04/30

年度報告

Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2020/03/11

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/02

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/29

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/08/26

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/04/30

年度報告

Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2019/03/19

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/03/19

超過5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/01/16

超過5%披露

[Amend] General statement of acquisition of beneficial ownership
2018/12/07

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/08/30

非美公司披露報告

2018/04/04

非美公司披露報告

更多